Few reports suggest for possible role of LY75 in malignant diseases; thus, LY75 has been reported as suppressed in colorectal [34] and breast cancer [35], but universally expressed in both bladder carcinomas and normal urothelium [36] and induced in thymoma [37]. Here, LY75 is linked to thymoma.